欢迎登录材料期刊网

材料期刊网

高级检索

以自制的琥珀酰化壳聚糖(SUCS)和羟甲基-5-氟尿嘧啶(5-FuOH)为原料,制备了壳聚糖偶联载药体(SUCS-5-FuOH)。傅里叶红外光谱(FT-IR)、核磁共振(1 H-NMR )、热重(TG )和 X 粉末衍射(XRD)等技术表征了产物的化学结构、热稳定性和结晶行为。并通过紫外光谱(UV )分析了产物对5-FuOH 的接枝率及其体外释药行为。结果表明,SUCS和5-FuOH 间通过酯键化学键合,接枝率(载药率)为18.7%,在模拟体液和酶存在条件下均有良好的缓释性能。

Chitosan coupling drug-loading body (SUCS-5-FuOH)was prepared with homemade succinyl-chi-tosan (SUCS)and hydroxymethyl-5-fluorouracil (5-FuOH)as materials.The chemical structure,thermal sta-bility and crystallization behavior of the obtained sample were characterized by Fourier infrared spectrum (FT-IR),nuclear magnetic resonance (1 H-NMR),thermal gravimetric analysis (TG)and X-ray powder diffraction (XRD).The grafting rate of 5-FuOH and the in vitro releasing performance were analysed by UV spectrum (UV).The results indicated that SUCS and 5-FuOH were chemically bonded through ester linkage,the graft-ing rate (drug loading rate)of SUCS-5-FuOH was 18.7%,and it had good sustained-release performance under the condition of simulated body fluids and enzymes.

参考文献

[1] Ringsdorf H .Structure and properties of pharmacologi-cally active polymers[J].Journal of Applied Polymer Science,Applied Polymer Symposium,1975,51:135-153.
[2] Greco F;Anat E;Ronit S et al.Synthesis and biological evaluation of a poltglutamic acid-dopamine conj ugate:a new antiangiogenic agent[J].Medicinal Chemistry,2008,13:2744-2756.
[3] Vicent M J;Greco F;Nicholson R I et al.Polymer therapeufics designed for a combination therapy of hor-mone-dependent cancer[J].Angewandte Chemie International Edition in English,2005,44(26):4061-4066.
[4] 刘亮,晋平,程明,张国亮,张凤宝.载5-氟尿嘧啶的pH敏感自组装纳米粒制备及体外释放[J].中国化学工程学报(英文版),2006(03):377-382.
[5] Liao Jun;Zhuo Ranxi .Synthesis,hydrolysis and antitu-mor activity of conjugates of 5-fluorouracil with poly(L-iysine)[J].Polymer Journal,1993,25(04):401-405.
[6] 严慧,邱飞,刁勇.5-氟尿嘧啶高分子前药与靶向给药[J].高分子通报,2011(06):22-29.
[7] Ashish Dev;N.S. Binulal;A. Anitha .Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications[J].Carbohydrate Polymers: Scientific and Technological Aspects of Industrially Important Polysaccharides,2010(3):833-838.
[8] Sarmila Sahoo;Abhisek Sasmal;Rajashree Nanda .Synthesis of chitosan-polycaprolactone blend for control delivery of ofloxacin drug[J].Carbohydrate Polymers: Scientific and Technological Aspects of Industrially Important Polysaccharides,2010(1):106-113.
[9] Eva M. Martin del Valle;Miguel A. Galan;Ruben G. Carbonell .Drug Delivery Technologies: The Way Forward in the New Decade[J].Industrial & Engineering Chemistry Research,2009(5):2475-2486.
[10] V.K. Mourya;Nazma N. Inamdar .Chitosan-modifications and applications: Opportunities galore[J].Reactive & functional polymers,2008(6):1013-1051.
[11] 王银松;李英霞;宋妮 等.甲氨蝶呤-乳糖酰化壳聚糖的制备及其实验[J].高等学校化学学报,2007,24(11):2103-2106.
[12] 霍美蓉,周建平,张勇,吕霖.新型两亲性壳聚糖衍生物的合成、表征及对难溶性药物的增溶性[J].高等学校化学学报,2007(10):1995-1999.
[13] Fang Yuan,Fu Chen,Qing Yu Xiang,Xuan Qin,Zhi Rong Zhang,Yuan Huang.Synthesis and characterization of HPMA copolymer-5-FU conjugates[J].中国化学快报(英文版),2008(02):137-140.
[14] 范昌烈;麦才松;余惠.高分子药物研究(v)-1,3-二羟烷基-5-氟尿嘧啶的合成[J].武汉大学学报,1984(02):115-118.
[15] 李和平,阮建明,蔡红革,潘彤.壳聚糖-5-氟尿嘧啶高分子前药的合成与表征[J].长沙理工大学学报(自然科学版),2005(04):84-88.
[16] 王银松,李英霞,宋妮,张华.靶向抗肿瘤药物甲氨喋呤-琥珀酰壳聚糖缀合物的制备及其体外稳定性的初步探讨[J].高等学校化学学报,2003(11):2103-2106.
[17] 常军,郑玉斌,段久芳,尚宏周,吕婵婷.含5-氟尿嘧啶的聚乙二醇酯的制备与表征[J].现代化工,2006(03):40-42.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%